Maxim Group Analysts Give Capnia, Inc. (SLNO) a $25.00 Price Target

Capnia, Inc. (NASDAQ:SLNO) has been assigned a $25.00 price objective by equities researchers at Maxim Group in a research note issued on Thursday. The brokerage currently has a “buy” rating on the stock.

Separately, ValuEngine raised shares of Capnia from a “strong sell” rating to a “sell” rating in a research report on Friday, October 6th.

Shares of Capnia (SLNO) traded up 0.39% during midday trading on Thursday, hitting $2.58. 50,007 shares of the company’s stock were exchanged. The company has a 50-day moving average of $2.73 and a 200-day moving average of $2.86. The firm’s market cap is $24.73 million. Capnia has a 52 week low of $0.49 and a 52 week high of $6.60.

Capnia (NASDAQ:SLNO) last issued its quarterly earnings data on Friday, August 11th. The company reported ($0.30) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.40) by $0.10. Capnia had a negative net margin of 1,389.76% and a negative return on equity of 69.67%. Equities research analysts expect that Capnia will post ($1.35) EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Maxim Group Analysts Give Capnia, Inc. (SLNO) a $25.00 Price Target” was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at

Capnia Company Profile

Soleno Therapeutics, Inc, formerly Capnia, Inc, is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief.

Receive News & Ratings for Capnia Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capnia Inc. and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply